Context Matters Releases Proprietary Reimbursement Risk Tracker(TM) to Provide Reimbursement Insights for Pharmaceutical Development
September 25, 2012 09:35 ET
|
Context Matters
NEW YORK, Sept. 25, 2012 (GLOBE NEWSWIRE) -- Context Matters, a next generation healthcare data and analytics company focusing on risk assessment metrics for pharmaceutical and biotechnology products,...
Clinical Trial Results, When Overlapped With Health Technology Assessments, Provides More Complete Outlook for Reimbursement Decisions
June 27, 2012 08:45 ET
|
Context Matters
PHILADELPHIA, June 27, 2012 (GLOBE NEWSWIRE) -- A recent global comparison between clinical outcomes and Health Technology Assessments (HTAs) – which are often influential in decision making for...